Exosomes derived from N2 neutrophils reprogram the immune microenvironment to promote spinal cord injury repair
4 affiliations
- 1Taizhou Second People's Hospital Affiliated to Yangzhou University, Taizhou, Jiangsu, 225500, China
- 2School of Medicine, Nantong University, Nantong, Jiangsu, 226001, China
- 3Department of Infection, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, 200032, China
- 4Department of Cardiology, Taizhou People's Hospital, Taizhou, Jiangsu, 225300, China
Abstract
Introduction: Spinal cord injury induces irreversible neurological impairments via secondary pathological cascades dominated by excessive inflammation, oxidative stress, and neuronal apoptosis. As the first-responder immune cells following spinal cord trauma, neutrophils can acquire an N2-like reparative phenotype, yet direct neutrophil transplantation is hampered by poor cellular survival. Exosomes, nanoscale cell-secreted vesicles with low immunogenicity and favourable biostability, constitute promising cell-free candidates for regenerative therapy. Nevertheless, the therapeutic potential of exosomes derived from N2-polarized neutrophils remains poorly defined for spinal cord injury repair.
Methods: Murine bone-marrow-derived neutrophils were polarized toward the N2 phenotype using interleukin-6 (IL-6) and granulocyte-colony-stimulating factor (G-CSF), with non-polarized neutrophils set as the control group. Exosomes were purified by ultracentrifugation and comprehensively characterized by transmission electron microscopy, nanoparticle tracking analysis, and western blotting. In vitro functional assays were performed to evaluate macrophage phenotypic reprogramming, neuronal axonal regeneration, and neuronal apoptosis. A modified Allen's weight-drop mouse spinal cord injury model was adopted for in vivo intervention. Motor functional recovery was evaluated using the Basso Mouse Scale and gait analysis, while neural tissue repair was assessed via immunofluorescence staining.
Results: Exosomes derived from N2-polarized neutrophils (N2-exos) exhibited canonical exosomal hallmarks. In vitro, these exosomes drove lipopolysaccharide-primed macrophages to switch to an anti-inflammatory reparative phenotype, alleviated oxidative-stress-mediated axonal injury, and suppressed neuronal apoptosis. In vivo administration of N2-exos markedly enhanced hind-limb motor performance and gait coordination, and facilitated axonal regeneration across the injury epicenter.
Conclusions: N2-exos remodel the post-traumatic immune microenvironment and confer combined neuroprotective and axon regenerative effects. This cell-free modality represents a promising therapeutic candidate for regenerative interventions against spinal cord injury.
Related
- DVT-primed neutrophils reshape the brain microenvironment to promote brain metastasis
- Exosomes derived from bone substitute-induced gingival mesenchymal stem cells promote angiogenesis.
- M2 macrophage-derived exosomes promote the malignant progression and glycolysis of cervical cancer via Msi1
- Immune cell-derived exosomes in the tumor microenvironment: mechanisms of immune evasion and emerging therapeutic strategies in cancer immunotherapy
- Dual‐Targeted M1 Macrophage Extracellular Vesicles Reprogram the Tumor Microenvironment and Enhance Natural Killer Cell Immunotherapy in Breast Cancer
BibTeX
@article{qian2026exosomes,
title = {{Exosomes derived from N2 neutrophils reprogram the immune microenvironment to promote spinal cord injury repair}},
author = {Rong Qian and Ruilin Chen and Rubin Jing and Wen Zhang},
journal = {Regenerative Therapy},
year = {2026},
month = oct,
doi = {10.1016/j.reth.2026.101196},
url = {https://doi.org/10.1016/j.reth.2026.101196},
note = {CC BY-NC-ND 4.0},
}
RIS
TY - JOUR
TI - Exosomes derived from N2 neutrophils reprogram the immune microenvironment to promote spinal cord injury repair
AU - Rong Qian
AU - Ruilin Chen
AU - Rubin Jing
AU - Wen Zhang
PY - 2026
DA - 2026/10/28
JO - Regenerative Therapy
DO - 10.1016/j.reth.2026.101196
UR - https://doi.org/10.1016/j.reth.2026.101196
AB - Introduction: Spinal cord injury induces irreversible neurological impairments via secondary pathological cascades dominated by excessive inflammation, oxidative stress, and neuronal apoptosis. As the first-responder immune cells following spinal cord trauma, neutrophils can acquire an N2-like reparative phenotype, yet direct neutrophil transplantation is hampered by poor cellular survival. Exosomes, nanoscale cell-secreted vesicles with low immunogenicity and favourable biostability, constitute promising cell-free candidates for regenerative therapy. Nevertheless, the therapeutic potential of exosomes derived from N2-polarized neutrophils remains poorly defined for spinal cord injury repair. Methods: Murine bone-marrow-derived neutrophils were polarized toward the N2 phenotype using interleukin-6 (IL-6) and granulocyte-colony-stimulating factor (G-CSF), with non-polarized neutrophils set as the control group. Exosomes were purified by ultracentrifugation and comprehensively characterized by transmission electron microscopy, nanoparticle tracking analysis, and western blotting. In vitro functional assays were performed to evaluate macrophage phenotypic reprogramming, neuronal axonal regeneration, and neuronal apoptosis. A modified Allen's weight-drop mouse spinal cord injury model was adopted for in vivo intervention. Motor functional recovery was evaluated using the Basso Mouse Scale and gait analysis, while neural tissue repair was assessed via immunofluorescence staining. Results: Exosomes derived from N2-polarized neutrophils (N2-exos) exhibited canonical exosomal hallmarks. In vitro, these exosomes drove lipopolysaccharide-primed macrophages to switch to an anti-inflammatory reparative phenotype, alleviated oxidative-stress-mediated axonal injury, and suppressed neuronal apoptosis. In vivo administration of N2-exos markedly enhanced hind-limb motor performance and gait coordination, and facilitated axonal regeneration across the injury epicenter. Conclusions: N2-exos remodel the post-traumatic immune microenvironment and confer combined neuroprotective and axon regenerative effects. This cell-free modality represents a promising therapeutic candidate for regenerative interventions against spinal cord injury.
SN - 2352-3204
ER -